English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Mar 25, 2026
Researchers report hepatitis C drug may stop hepatitis E virus replication
Patient Daily
| Mar 25, 2026
Oral semaglutide does not slow early Alzheimer’s decline in phase 3 trials, study finds
Patient Daily
| Mar 25, 2026
GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
Patient Daily
| Mar 25, 2026
Experts discuss evolving guidelines for blood pressure control in older adults
Patient Daily
| Mar 25, 2026
Losing health insurance worsens diabetes outcomes in low-income adults
Patient Daily
| Mar 25, 2026
Study finds addiction risk tied to reward and impulse genes
Patient Daily
| Mar 24, 2026
Researchers identify new immune response mechanism with implications for cancer treatment
Patient Daily
| Mar 23, 2026
Ohio State Wexner Medical Center highlights role of palliative care for serious illness
Trending
+
Regulatory
A. D. Alderman
| Jun 11, 2026
Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+
Regulatory
A. D. Ahrens
| Jun 11, 2026
Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+
Regulatory
Patient Daily
| Jun 16, 2026
PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+
Regulatory
Patient Daily
| Jun 12, 2026
Taxpayer advocate: 340B drug discount program offers 'perverse incentives'
« First
«
…
50
51
52
53
54
55
56
…
»
Last »